AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
26 hedge funds and large institutions have $683K invested in Agile Therapeutics in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
47% less capital invested
Capital invested by funds: $1.28M → $683K (-$599K)
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$122K | |
| 2 | +$76.8K | |
| 3 | +$58.7K | |
| 4 |
Millennium Management
New York
|
+$50K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$23K |
Top Sellers
| 1 | -$22K | |
| 2 | -$16.3K | |
| 3 | -$6.75K | |
| 4 |
Two Sigma Investments
New York
|
-$5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$214 |